Furthermore, loss of CdGAP delayed tumor initiation, decreased tumor volume and tumor size in subcutaneous xenografts, and reduced distant metastasic burden in an orthotopic model of prostate cancer. The gene discussed is ARHGAP31; the disease is Familial prostate cancer.